PATH EX, a Houston, TX-based medical device company, raised $5M in funding.
The round was led by IAG Capital Partners with participation from TMC Venture Fund and Fitz Gate Ventures.
The company intends to use the funds to accelerate the development and future commercialization of CycloPE®.
Led by CEOSinead Miller, PATH EX, Inc. is a medical device company developing CycloPE®, a medical device designed to rapidly eradicate bacteria from the bloodstream in patients suffering from sepsis.
In parallel with this financing, PATH EX added Jeff Burbank to the Board of Directors.
FinSMEs
09/05/2025